The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review
- PMID: 23422269
- DOI: 10.1016/j.semarthrit.2012.12.002
The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review
Abstract
Objective: To perform a systematic review of the literature regarding the epidemiology of the association between systemic lupus erythematosus (SLE) and atherosclerotic cardiovascular disease (CVD), including the increased risk for CVD, as well as the risk factors responsible for development of CVD in patients with SLE.
Methods: We followed the PRISMA guidelines to systematically search the PubMed database from inception to June 2012. Studies were selected using predefined eligibility criteria, and 2 authors independently extracted data. The risk of bias was measured for each study using a domain-based assessment.
Results: We report on 28 studies that met criteria for inclusion in our analysis. We found strong epidemiologic evidence that SLE patients have an increased relative risk of CVD compared to controls. There is limited information regarding relative CVD mortality risks among SLE patients. Traditional CVD risk factors, including age, male sex, hyperlipidemia, smoking, hypertension, and CRP, are associated with CVD risk among SLE patients. Several SLE-specific factors, including disease activity and duration, and possibly specific manifestations and therapies, further increase risk. Several risk factors, such as disease activity and glucocorticoid use, are closely associated, making it difficult to disentangle their effects.
Conclusions: CVD risk among SLE patients compared to the general population is at least doubled. While older SLE patients appear to have the highest absolute risks of CVD, young women have alarmingly high relative risks, given the rarity of CVD in the comparison general population. Both traditional and SLE-specific risk factors are important, although there are discrepancies within the literature.
Keywords: Atherosclerosis; C-reactive protein; CABG; CAD; CHF; CRP; CV; CVA; CVD; Cardiovascular; Cohort study; Coronary artery disease; Epidemiology; MI; Myocardial infarction; PVD; Risk; Risk factors; SLE; Systemic lupus erythematosus; cardiovascular; cardiovascular disease; cerebrovascular accident; congestive heart failure; coronary artery bypass grafting; coronary artery disease; myocardial infarction; peripheral vascular disease; systemic lupus erythematosus.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: A systematic review and Meta-analysis.Int Immunopharmacol. 2021 May;94:107466. doi: 10.1016/j.intimp.2021.107466. Epub 2021 Feb 23. Int Immunopharmacol. 2021. PMID: 33636561
-
Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients.PLoS One. 2017 Aug 29;12(8):e0182483. doi: 10.1371/journal.pone.0182483. eCollection 2017. PLoS One. 2017. PMID: 28850570 Free PMC article.
-
Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis.Lupus. 2023 Mar;32(3):325-341. doi: 10.1177/09612033221147471. Epub 2022 Dec 22. Lupus. 2023. PMID: 36547368 Free PMC article.
-
Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review.J Rheumatol. 2016 Jan;43(1):54-65. doi: 10.3899/jrheum.150460. Epub 2015 Nov 15. J Rheumatol. 2016. PMID: 26568591 Review.
-
[Atherosclerosis in systemic lupus erythematosus].Presse Med. 2014 Oct;43(10 Pt 1):1034-47. doi: 10.1016/j.lpm.2014.01.021. Epub 2014 Sep 5. Presse Med. 2014. PMID: 25201598 Review. French.
Cited by
-
Beyond the Heart: The Predictive Role of Coronary Artery Calcium Scoring in Non-Cardiovascular Disease Risk Stratification.Diagnostics (Basel). 2024 Oct 22;14(21):2349. doi: 10.3390/diagnostics14212349. Diagnostics (Basel). 2024. PMID: 39518317 Free PMC article. Review.
-
Beneficial effects of hydroxychloroquine on blood lipids and glycated haemoglobin: A randomised interventional study in patients with rheumatoid arthritis and systemic lupus erythematosus.PLoS One. 2024 Oct 28;19(10):e0312546. doi: 10.1371/journal.pone.0312546. eCollection 2024. PLoS One. 2024. PMID: 39466791 Free PMC article. Clinical Trial.
-
The Anti-Inflammatory Effect of Lactococcus lactis-Ling-Zhi 8 on Ameliorating Atherosclerosis and Nonalcoholic Fatty Liver in High-Fat Diet Rabbits.Int J Mol Sci. 2024 Oct 20;25(20):11278. doi: 10.3390/ijms252011278. Int J Mol Sci. 2024. PMID: 39457059 Free PMC article.
-
Real-world treatment patterns in patients with systemic lupus erythematosus: associations with comorbidities and damage.Lupus Sci Med. 2024 Sep 24;11(2):e001266. doi: 10.1136/lupus-2024-001266. Lupus Sci Med. 2024. PMID: 39317452 Free PMC article.
-
Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus.Arthritis Res Ther. 2024 Sep 14;26(1):160. doi: 10.1186/s13075-024-03395-6. Arthritis Res Ther. 2024. PMID: 39272198 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
